Papers
1
Total Citations
33
H-Index
1
About
Zhongsan Su is a rising figure in urologic oncology, whose research centers on advancing minimally invasive surgical techniques for prostate cancer. His most impactful work, a 2021 meta-analysis comparing single-port (SP) versus multiport robot-assisted radical prostatectomy (RARP), has garnered 33 citations and provides critical clarity on the comparative performance of next-generation robotic platforms. By systematically evaluating perioperative and oncologic outcomes, Su’s synthesis helps resolve the clinical equipoise surrounding the da Vinci SP system versus its Xi and Si predecessors, offering evidence-based guidance for surgeons adopting this novel technology. Beyond this flagship study, his broader contributions explore the frontiers of robotic surgery, patient safety, and oncologic efficacy. Su’s work demonstrates a commitment to refining surgical standards through rigorous data analysis, directly impacting operative decision-making and postoperative quality of life for prostate cancer patients. As robotic platforms evolve, his meta-analytic approach serves as a model for integrating emerging technologies into practice, marking him as a thoughtful contributor to the future of urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1